Vicki Wheelock
Neurology · Sacramento, CANPI 1871579458
Payments from drug & device makers
Across 45 payments — averaging $19,376 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$815K
- F. Hoffmann-la Roche AG$46K
- Roche Products Limited$10K
- Teva Pharmaceuticals USA, Inc.$177
What the payments were for
- Consulting fees$16,35099%
- Food & beverage$170%
- Education$1771%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 26 | $815,132 |
| F. Hoffmann-la Roche AG | 7 | $46,450 |
| Roche Products Limited | 10 | $10,167 |
| Teva Pharmaceuticals USA, Inc. | 2 | $177 |
How this compares
$871,926 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AustedoDeutetrabenazine | 12 | $91,470 |
| RytaryCarbidopa/Levodopa | 20 | $38,369 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 30 | $3,375 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 13 | $397 |
| Olanzapine | 25 | $283 |
| Donepezil Hcl | 12 | $176 |
| Tizanidine Hcl | 11 | $148 |
| Sertraline Hcl | 11 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo | $177 | $91,47012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,996 neurology providers in California.
Other neurology in Sacramento
- Michelle AppersonSacramento$2.5M
- Timothy CloughesyLos Angeles$33.1M
- Jack FlorinFullerton$13M
- David KudrowSanta Monica$12.8M
- John Ravitsla Jolla$8.4M
- Perminder BhatiaFresno$8.3M
- Perry ShiehLos Angeles$8.2M
- Benjamin FrishbergCarlsbad$8.2M
- Bruce CreeSan Francisco$8M
- Lawrence RechtPalo Alto$6.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.